These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 30354576)
1. Relationship Between Enrolling Country Income Level and Patient Profile, Protocol Completion, and Trial End Points. Greene SJ; Hernandez AF; Sun JL; Butler J; Armstrong PW; Ezekowitz JA; Zannad F; Ferreira JP; Coles A; Metra M; Voors AA; Califf RM; O'Connor CM; Mentz RJ Circ Cardiovasc Qual Outcomes; 2018 Oct; 11(10):e004783. PubMed ID: 30354576 [TBL] [Abstract][Full Text] [Related]
2. Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure). Greene SJ; Hernandez AF; Sun JL; Metra M; Butler J; Ambrosy AP; Ezekowitz JA; Starling RC; Teerlink JR; Schulte PJ; Voors AA; Armstrong PW; O'Connor CM; Mentz RJ Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623769 [TBL] [Abstract][Full Text] [Related]
3. Representativeness of a Heart Failure Trial by Race and Sex: Results From ASCEND-HF and GWTG-HF. Greene SJ; DeVore AD; Sheng S; Fonarow GC; Butler J; Califf RM; Hernandez AF; Matsouaka RA; Samman Tahhan A; Thomas KL; Vaduganathan M; Yancy CW; Peterson ED; O'Connor CM; Mentz RJ JACC Heart Fail; 2019 Nov; 7(11):980-992. PubMed ID: 31606362 [TBL] [Abstract][Full Text] [Related]
4. Acute Heart Failure and Atrial Fibrillation: Insights From the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF) Trial. Abualnaja S; Podder M; Hernandez AF; McMurray JJ; Starling RC; O'Connor CM; Califf RM; Armstrong PW; Ezekowitz JA J Am Heart Assoc; 2015 Aug; 4(8):e002092. PubMed ID: 26304935 [TBL] [Abstract][Full Text] [Related]
5. Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure). Bhatt AS; Cooper LB; Ambrosy AP; Clare RM; Coles A; Joyce E; Krishnamoorthy A; Butler J; Felker GM; Ezekowitz JA; Armstrong PW; Hernandez AF; O'Connor CM; Mentz RJ J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29431103 [TBL] [Abstract][Full Text] [Related]
6. Hypotension during hospitalization for acute heart failure is independently associated with 30-day mortality: findings from ASCEND-HF. Patel PA; Heizer G; O'Connor CM; Schulte PJ; Dickstein K; Ezekowitz JA; Armstrong PW; Hasselblad V; Mills RM; McMurray JJ; Starling RC; Tang WH; Califf RM; Hernandez AF Circ Heart Fail; 2014 Nov; 7(6):918-25. PubMed ID: 25281655 [TBL] [Abstract][Full Text] [Related]
7. Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF). Howlett JG; Ezekowitz JA; Podder M; Hernandez AF; Diaz R; Dickstein K; Dunlap ME; Corbalán R; Armstrong PW; Starling RC; O'Connor CM; Califf RM; Fonarow GC; Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):534-42. PubMed ID: 23899930 [TBL] [Abstract][Full Text] [Related]
8. Acute study of clinical effectiveness of nesiritide in decompensated heart failure: nesiritide redux. Pleister AP; Baliga RR; Haas GJ Curr Heart Fail Rep; 2011 Sep; 8(3):226-32. PubMed ID: 21695395 [TBL] [Abstract][Full Text] [Related]
9. Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure). Grodin JL; Perez AL; Wu Y; Hernandez AF; Butler J; Metra M; Felker GM; Voors AA; McMurray JJ; Armstrong PW; Califf RM; Starling RC; O'Connor CM; Tang WH JACC Heart Fail; 2015 Oct; 3(10):777-85. PubMed ID: 26449997 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Role of Prior Heart Failure Hospitalization Among Patients Hospitalized for Worsening Chronic Heart Failure. Blumer V; Mentz RJ; Sun JL; Butler J; Metra M; Voors AA; Hernandez AF; O'Connor CM; Greene SJ Circ Heart Fail; 2021 Apr; 14(4):e007871. PubMed ID: 33775110 [TBL] [Abstract][Full Text] [Related]
12. Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial. Greene SJ; Hernandez AF; Dunning A; Ambrosy AP; Armstrong PW; Butler J; Cerbin LP; Coles A; Ezekowitz JA; Metra M; Starling RC; Teerlink JR; Voors AA; O'Connor CM; Mentz RJ J Am Coll Cardiol; 2017 Jun; 69(25):3029-3039. PubMed ID: 28641792 [TBL] [Abstract][Full Text] [Related]
13. Acute heart failure: perspectives from a randomized trial and a simultaneous registry. Ezekowitz JA; Hu J; Delgado D; Hernandez AF; Kaul P; Leader R; Proulx G; Virani S; White M; Zieroth S; O'Connor C; Westerhout CM; Armstrong PW Circ Heart Fail; 2012 Nov; 5(6):735-41. PubMed ID: 23032196 [TBL] [Abstract][Full Text] [Related]
14. The ASCEND-HF trial: an acute study of clinical effectiveness of nesiritide and decompensated heart failure. Dandamudi S; Chen HH Expert Rev Cardiovasc Ther; 2012 May; 10(5):557-63. PubMed ID: 22651831 [TBL] [Abstract][Full Text] [Related]
15. The relationship between left ventricular ejection fraction and mortality in patients with acute heart failure: insights from the ASCEND-HF Trial. Toma M; Ezekowitz JA; Bakal JA; O'Connor CM; Hernandez AF; Sardar MR; Zolty R; Massie BM; Swedberg K; Armstrong PW; Starling RC Eur J Heart Fail; 2014 Mar; 16(3):334-41. PubMed ID: 24464687 [TBL] [Abstract][Full Text] [Related]
16. Nesiritide in patients hospitalized for acute heart failure: does timing matter? Implication for future acute heart failure trials. Wong YW; Mentz RJ; Felker GM; Ezekowitz J; Pieper K; Heizer G; Hasselblad V; Metra M; O'Connor CM; Armstrong PW; Starling RC; Hernandez AF Eur J Heart Fail; 2016 Jun; 18(6):684-92. PubMed ID: 26817735 [TBL] [Abstract][Full Text] [Related]
17. Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF). van Deursen VM; Hernandez AF; Stebbins A; Hasselblad V; Ezekowitz JA; Califf RM; Gottlieb SS; O'Connor CM; Starling RC; Tang WH; McMurray JJ; Dickstein K; Voors AA Circulation; 2014 Sep; 130(12):958-65. PubMed ID: 25074507 [TBL] [Abstract][Full Text] [Related]
18. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. Sackner-Bernstein JD; Kowalski M; Fox M; Aaronson K JAMA; 2005 Apr; 293(15):1900-5. PubMed ID: 15840865 [TBL] [Abstract][Full Text] [Related]
19. Pharmacoeconomic modeling of nesiritide versus dobutamine for decompensated heart failure. Gerhard T; Zineh I; Winterstein AG; Hartzema AG Pharmacotherapy; 2006 Jan; 26(1):34-43. PubMed ID: 16509026 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure. Tang WH; Wu Y; Grodin JL; Hsu AP; Hernandez AF; Butler J; Metra M; Voors AA; Felker GM; Troughton RW; Mills RM; McMurray JJ; Armstrong PW; O'Connor CM; Starling RC JACC Heart Fail; 2016 Jan; 4(1):68-77. PubMed ID: 26656144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]